Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Adverum Biotechnologies Inc
(NQ:
ADVM
)
9.790
+0.070 (+0.72%)
Official Closing Price
Updated: 4:15 PM EDT, May 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Adverum Biotechnologies Inc
< Previous
1
2
3
4
Next >
Why Adverum Biotechnologies Stock Is Imploding Today
April 29, 2021
Investors are running for the hills following the company's latest clinical update.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For April 29, 2021
April 29, 2021
Upgrades According to Vertical Research, the prior rating for Entergy Corp (NYSE:ETR) was changed from Hold to Buy. For the first quarter, Entergy had an EPS of $1.47,...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
April 29, 2021
During Thursday's morning trading, 5 companies set new 52-week lows. Noteables: Lufax Holding (NYSE:LU) was the largest firm on a market cap basis to set a new...
Via
Benzinga
Mid-Morning Market Update: Markets Open Higher; McDonald's Profit Beats Estimates
April 29, 2021
Following the market opening Thursday, the Dow traded up 0.23% to 33,899.83 while the NASDAQ rose 0.25% to 14,086.11. The S&P also rose, gaining 0.49% to 4,203.60. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx
April 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 29, 2021
Gainers Galera Therapeutics (NASDAQ:GRTX) shares increased by 42.2% to $9.4 during Thursday's pre-market session. The market value of their outstanding shares is at $...
Via
Benzinga
28 Stocks Moving in Thursday's Pre-Market Session
April 29, 2021
Gainers Galera Therapeutics, Inc. (NASDAQ: GRTX) rose 39.6% to $9.23 in pre-market trading after the company disclosed updated data from its randomized, multicenter, placebo-...
Via
Benzinga
Adverum's Stock Crashes After DME Gene Therapy Trial Derails On One Patient's Serious Adverse Event
April 29, 2021
Adverum Biotechnologies Inc (NASDAQ: ADVM) stock has cratered in reaction to a Suspected Unexpected Serious Adverse Reaction of hypotony (clinically-relevant decrease...
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
April 12, 2021
Before 10 a.m. ET on Monday, 30 stocks hit new 52-week lows. Interesting Highlights: The largest company by market cap to set a new 52-week low was Ionis Pharmaceuticals (...
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
April 16, 2021
Before 10 a.m. ET Friday, 62 stocks made new 52-week lows. Significant Points: The largest company by market cap to set a new 52-week low was Yatsen Holding (NYSE:...
Via
Benzinga
The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead
April 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 13) Bio-Techne Corporation (...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug
April 13, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 12) 180 Life Sciences Corp. (...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.